Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party.

December 2, 2015 at 10:49 pm

J Hosp Infect. 2015 Nov 14. pii: S0195-6701(15)00314-X.

Wilson AP1, Livermore DM2, Otter JA3, Warren RE4, Jenks P5, Enoch DA6, Newsholme W7, Oppenheim B8, Leanord A9, McNulty C10, Tanner G11, Bennett S12, Cann M13, Bostock J14, Collins E15, Peckitt S16, Ritchie L17, Fry C18, Hawkey P19.

Author information

1Consultant Microbiologist, Department of Microbiology and Virology, University College London Hospitals, London, UK. Electronic address: peter.wilson@uclh.nhs.uk.

2Professor of Medical Microbiology, Norwich Medical School, University of East Anglia, Norwich, UK.

3Research Fellow, Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St. Thomas’ NHS Foundation Trust and King’s College London, London, UK.

4Retired Consultant Microbiologist, Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK.

5Consultant Microbiologist, Plymouth Hospitals NHS Trust, Plymouth, UK.

6Consultant Microbiologist, Public Health England, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

7Consultant in Infectious Diseases, Infection Control and General Medicine, Department of Infection, St Thomas’ Hospital, London, UK.

8Consultant Microbiologist, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Queen Elizabeth Medical Centre, Birmingham, UK.

9Consultant Microbiologist, Southern General Hospital, Glasgow, UK.

10Head of Primary Care Unit, Public Health England, and Honorary Visiting Professor Cardiff University, Microbiology Department, Gloucester Royal Hospital, Gloucester, UK.

11Patient Representative, Bristol, UK.

12Patient Representative, Member of Health Care Acquired Infections, Service Users Research Forum, Leicester, UK.

13Trustee, MRSA Action, Kirkham, UK.

14Patient Representative, Member of Health Care Acquired Infections, Service Users Research Forum, London, UK.

15Clinical Lead Infection Prevention, University Hospitals of Leicester, Leicester Royal Infirmary, Leicester, UK.

16Infection Prevention and Control Lead for North Yorkshire and Humber Commissioning Support Unit, Hull, UK.

17Nurse Consultant Infection Control, Infection Control Team/HAI Group, Health Protection Scotland, Glasgow, UK.

18Nursing Officer – Communicable Diseases Infectious Diseases and Blood Policy, Department of Health, London, UK.

19Professor of Clinical and Public Health Bacteriology, Consultant Medical Microbiologist, Public Health Laboratory, Birmingham Heartlands Hospital, Bordesley Green East, Birmingham, UK.

Multi-drug-resistant (MDR) Gram-negative bacterial infections have become prevalent in some European countries. Moreover, increased use of broad-spectrum antimicrobial agents selects organisms with resistance and, by increasing their numbers, increases their chance of spread.

This report describes measures that are clinically effective for preventing transmission when used by healthcare workers in acute and primary healthcare premises.

Methods for systematic review 1946–2014 were in accordance with SIGN 501 and the Cochrane Collaboration;2 critical appraisal was applied using AGREEII.

abstract

http://www.journalofhospitalinfection.com/article/S0195-6701(15)00314-X/abstract

PDF

http://www.journalofhospitalinfection.com/article/S0195-6701(15)00314-X/pdf

Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Desinfection and Sterilization, Epidemiología, Health Care-Associated Infections, Infecciones emergentes, Infecciones nosocomiales, Metodos diagnosticos, REPORTS, Resistencia bacteriana, Sepsis, Update. Tags: .

Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study Ending the HIV–AIDS Pandemic — Follow the Science


Calendar

December 2015
M T W T F S S
« Nov   Jan »
 123456
78910111213
14151617181920
21222324252627
28293031  

Most Recent Posts


%d bloggers like this: